publication venue for
- G3BP1 modulates SPOP to promote prostate tumorigenesis.. 9. 2022
- Targeting cancer's sweet spot: UGP2 as a therapeutic vulnerability.. 8. 2021
- Ketosis versus carbotoxicity - metabolism determines the outcome of cancer immunotherapy.. 8. 2021
- A fasting-mimicking diet and vitamin C: turning anti-aging strategies against cancer.. 7. 2020
- Histone H3 variants at the root of metastasis.. 7. 2020
- When fat goes down, prostate cancer is on the ropes.. 6. 2019
- Etiological involvement of CFTR in apparently unrelated human diseases.. 6. 2018
- Dynamic ERK signaling regulation in intestinal tumorigenesis.. 5. 2018
- SWI/SNF tumor suppressor gene PBRM1/BAF180 in human clear cell kidney cancer.. 4. 2017
- PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN.. 4. 2017
- BAK regulates catalase release from peroxisomes.. 4. 2017
- Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma.. 3. 2015
- Taspase 1: A protease with many biological surprises.. 2. 2015
- Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer.. 2. 2015
- Molecular and Cellular Oncology: A new journal for a changing field.. 1. 2014
- Molecular and Cellular Oncology: A new journal for a changing field.. 1. 2014
- Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression. 2015
- Trial Watch: Proteasomal inhibitors for anticancer therapy. 2014
- Chloroquine and hydroxychloroquine for cancer therapy. 2014